Accord | Jotup

Honda Announces Next Steps in Preparation for U.S. EV Production

Retrieved on:

Wednesday, March 15, 2023

This EV Hub will play a key role in developing the company?s knowledge and expertise in EV production that will be shared across Honda?s entire North American auto production network in the coming years, even as many Honda plants continue production of gasoline-powered vehicles.

Key Points:

This EV Hub will play a key role in developing the company?s knowledge and expertise in EV production that will be shared across Honda?s entire North American auto production network in the coming years, even as many Honda plants continue production of gasoline-powered vehicles.
Each Honda auto production facility in North America will have a critical role to play in Honda?s electrification strategy.
This will maintain production volume of an important core model for Honda customers, while enabling MAP to transition to EV production.
Even as Honda accelerates preparation for EV production, the company plans to sustain current ICE and hybrid-electric vehicle production in order to continue to meet anticipated strong customer demand through 2030 and beyond.

Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results

Retrieved on:

Monday, March 13, 2023

During the fourth quarter of 2022, the Company reached the contractual limit for royalties paid to development partner on worldwide bendamustine profits.

Key Points:

During the fourth quarter of 2022, the Company reached the contractual limit for royalties paid to development partner on worldwide bendamustine profits.
“2022 was an outstanding year for Eagle, as we tripled our adjusted non-GAAP net income per diluted share over 2021.
Q4 2022 RYANODEX® net product sales were $7.2 million, compared to $6.1 million in the fourth quarter of 2021.
Q4 2022 BELRAPZO net product sales were $11.0 million, compared to $5.5 million in the fourth quarter of 2021.

Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS

Retrieved on:

Monday, March 13, 2023

MS, Lymphocyte, Risk, Multiple sclerosis, Intas Pharmaceuticals, Blood, Liver, Patient, Accord, Pregnancy, Safety, Birth, FDA, Inflammation, Liver failure, Pharmaceutical industry, Teriflunomide

DURHAM, N.C., March 13, 2023 /PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Teriflunomide to its portfolio of oral medications. The drug is formulated as a film-coated tablet. Accord's Teriflunomide is therapeutically equivalent to Sanofi Genzyme's Aubagio® and is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. Accord's product is offered in a 14mg tablet and a 7mg tablet and is currently available to ship.

Key Points:

DURHAM, N.C., March 13, 2023 /PRNewswire/ -- Accord Healthcare, Inc. , a leading generic pharmaceutical company, has added Teriflunomide to its portfolio of oral medications.
Accord's Teriflunomide is therapeutically equivalent to Sanofi Genzyme's Aubagio® and is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.
Accord's product is offered in a 14mg tablet and a 7mg tablet and is currently available to ship.
This is an important oral therapy for the millions of patients living with relapsing MS," said Accord Healthcare U.S. Vice President of Sales Jim Brown.

Accord Healthcare Offers Generic Option for Treatment of Schizophrenia and Bipolar Depression

Retrieved on:

Tuesday, February 21, 2023

DURHAM, N.C., Feb. 21, 2023 /PRNewswire/ -- Accord Healthcare, Inc. , a leading generic pharmaceutical company, has added Lurasidone HCL tablets to its line of generic drugs.

Key Points:

DURHAM, N.C., Feb. 21, 2023 /PRNewswire/ -- Accord Healthcare, Inc. , a leading generic pharmaceutical company, has added Lurasidone HCL tablets to its line of generic drugs.
Lurasidone is an oral, atypical antipsychotic, which is a first-line treatment option for the management of schizophrenia in adults and adolescents.
"A generic option in mental health treatment provides more accessible healthcare to those who are in need."
Adverse reactions 2 of lurasidone for treatment of schizophrenia and bipolar depression include somnolence, akathisia, which is a feeling of restlessness, anxiety, and/or agitation, and extrapyramidal symptoms.

The MolinaCares Accord Donates $150,000 to Build a New Pharmacy at CrossOver Healthcare Ministry Clinic

Retrieved on:

Thursday, January 26, 2023

The MolinaCares Accord (“MolinaCares”), in conjunction with Molina Healthcare of Virginia (“Molina”), presented a $150,000 check to CrossOver Healthcare Ministry (“CrossOver”) to fund construction of a new pharmacy for its Henrico clinic.

Key Points:

The MolinaCares Accord (“MolinaCares”), in conjunction with Molina Healthcare of Virginia (“Molina”), presented a $150,000 check to CrossOver Healthcare Ministry (“CrossOver”) to fund construction of a new pharmacy for its Henrico clinic.
The pharmacy, scheduled for groundbreaking in spring 2023, will double CrossOver’s capacity to provide prescription drugs to low-income, uninsured area residents who use the clinic’s services.
“As the only charitable clinic in Richmond with a licensed pharmacy on site, CrossOver’s community pharmacy is vital to the more than 6,600 clients we serve every year,” said Julie Bilodeau, CEO of CrossOver Healthcare Ministry.
“Increasing CrossOver’s capacity to serve aligns with MolinaCares’ focus on improving the health, life, and living in our local communities.”

Honda Civic Sedan, Hatchback, Type R and Accord take 2023 AutoTrader Awards

Retrieved on:

Friday, February 17, 2023

Civic, Assistant, Honda Civic Type R, Honda Civic, Honda Accord, Auto Trader, Auction, Automotive industry, Accord

Civic is best compact car, Type R wins best mainstream performance while Accord is the best family sedan in Canada

Key Points:

Civic is best compact car, Type R wins best mainstream performance while Accord is the best family sedan in Canada
MARKHAM, ON, Feb. 16, 2023 /CNW/ - Honda's most iconic nameplates have been awarded three significant 2023 AutoTrader Awards.
The built in Canada Honda Civic Sedan and the built in the U.S. Civic Hatchback were named Best Compact Car, the racetrack inspired Honda Civic Type R is the Best Mainstream Performance Car and the Honda Accord wins Best Family Sedan in Canada.
For more information on the 2023 Honda Civic go here.
For more information on the 2023 Honda Civic Type R go here.

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women a New State-of-the-Art Solution Powered by Artificial Intelligence

Retrieved on:

Monday, February 6, 2023

Woman, Breast imaging, Medicine, Cancer, Breast cancer, Algorithm, Patient, Eye, Health, Accord, Risk, EBCD, Radiology, RadNet, FDA, Breast, Overalls, AI, Medical imaging

EBCD presents a significantly improved level of accuracy in breast cancer detection, empowering women to take greater control of their health.

Key Points:

EBCD presents a significantly improved level of accuracy in breast cancer detection, empowering women to take greater control of their health.
RadNet is a global leader in the development and use of AI for cancer screening, and the use of AI is significantly featured in the Enhanced Breast Cancer Detection service.
While a breast density score, currently required in 38 states, is one factor in a patient's lifetime risk for breast cancer, multiple factors can increase risk.
The EBCD service offers a much-needed solution that addresses questions about breast cancer risk by providing a personalized report and a specialist to call when patients have questions about their lifetime risk of breast cancer.

Accord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer

Retrieved on:

Saturday, February 4, 2023

Intas Pharmaceuticals, Working Together, Diagnosis, Accord, Quality of life, Cancer, Patient

LONDON, Feb. 4, 2023 /PRNewswire/ -- Accord Healthcare (Accord), one of Europe's fastest growing pharmaceutical companies, marks World Cancer Day 2023 today by taking part in news-style programme for ITN Business alongside other partners from industry and the patient community to raise awareness of the importance of working together to improve the lives and health outcomes of people living with cancer.

Key Points:

LONDON, Feb. 4, 2023 /PRNewswire/ -- Accord Healthcare (Accord), one of Europe's fastest growing pharmaceutical companies, marks World Cancer Day 2023 today by taking part in news-style programme for ITN Business alongside other partners from industry and the patient community to raise awareness of the importance of working together to improve the lives and health outcomes of people living with cancer.
"With so many of us affected by cancer, this has been a really important and poignant programme to be part of.
Only through collaboration between cancer experts, industry, academia and patient organizations, can we make real progress toward a world without cancer.
'Working Together: To Tackle Cancer' launches on 4thFebruary 2023 to mark World Cancer Day and will be available to watch exclusively online at workingtogether.itn.co.uk.

Marketing Maven Named Public Relations Agency of Record for Visit Conejo Valley for Third Consecutive Year

Retrieved on:

Monday, January 23, 2023

Accord, Marketing, FAM, Travel, Restaurant, Tokushima Prefecture, Gumball 3000, Purchase order, Tourism, Telluride Ski Resort, Television, EVA Air, Social media, Sean, City, Reflexive relation, Atmosphere of Earth, Conejo Valley

THOUSAND OAKS, Calif., Jan. 23, 2023 /PRNewswire-PRWeb/ -- Marketing Maven, bicoastal, award-winning public relations firm, has announced that it has been retained as the public relations agency of record for Visit Conejo Valley, the official tourism marketing organization for the cities of Thousand Oaks and Agoura Hills, California, for the third consecutive year. The agency is charged with assisting to increase visitation that will bolster the local economy.

Key Points:

Visit Conejo Valley Proudly Partners with Local Firm, Marketing Maven, as PR Agency To Help Increase Tourism and Support the Local Economy
THOUSAND OAKS, Calif., Jan. 23, 2023 /PRNewswire-PRWeb/ -- Marketing Maven , bicoastal, award-winning public relations firm, has announced that it has been retained as the public relations agency of record for Visit Conejo Valley, the official tourism marketing organization for the cities of Thousand Oaks and Agoura Hills, California, for the third consecutive year.
Marketing Maven plans to continue its public relations strategy campaign for Visit Conejo Valley, inviting top-tier travel and hospitality media and influencers to the stay in the area to increase visitation.
"Marketing Maven is thrilled to remain the chosen public relations agency for Visit Conejo Valley," said Lindsey Carnett , CEO and President of Marketing Maven.
"With the help of Marketing Maven, we aim to attract visitors to Conejo Valley by utilizing their strategic methods," said Danielle Borja, President/CEO of Visit Conejo Valley .

2022's Most Junked Car Brands and Models in the US: A Report by Junk Car Medics

Retrieved on:

Monday, January 30, 2023

Civic, Longevity, Altima, Chevrolet, Ford Motor Company, Toyota Camry, Honda Accord (North America eighth generation), Nissan Altima, Accord, Honda Accord, Motor vehicle, Nissan

ROCHESTER, N.Y., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Junk Car Medics, a national junk car buying service in the USA, has released a report on the most junked car brands and models in 2022 based on an analysis of over 50,000 cars junked through their online portal.

Key Points:

ROCHESTER, N.Y., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Junk Car Medics, a national junk car buying service in the USA, has released a report on the most junked car brands and models in 2022 based on an analysis of over 50,000 cars junked through their online portal.
According to Junk Car Medics, Ford and Chevrolet had the highest percentages of junked cars in 2022, with 12.89% and 12.79%, respectively.
When looking at the most commonly junked car models, the Honda Accord took the top spot.
"At Junk Car Medics, we're always aiming to provide valuable resources that enable the general public to make informed decisions about their vehicles," said Todd Bialaszewski, CEO of Junk Car Medics.